Junko Fujisaki

28PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 27, 2026
Paradigm Shifts in Perioperative Management of Colorectal Cancer: Personalization Based on Tumor Biology, Primary Site, and Recurrence Risk, and the Evolving Role of Organ Preservation.

|Jun 02, 2026
New Compass for Precision Oncology: Evidence, Challenges, and Prospects of Circulating Tumor DNA in Colorectal Cancer.

|May 27, 2026
High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer.

|May 04, 2026
A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA.

|Mar 15, 2026
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.

Takeru Wakatsuki, Noriko Yamamoto, Naoki Ishizuka

|Dec 27, 2025
Ribosome biogenesis as a potential therapeutic target in KRAS mutant colorectal cancer.

Yui Tanaka, Mizuho Sakahara, Hitomi Yamanaka

Pageof 5

Frequent Collaborators

10 joint publications

Eiji Shinozaki

9 joint publications

Kensei Yamaguchi

8 joint publications

Akira Ooki

7 joint publications

Takeru Wakatsuki